ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3054 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 5.97 USD | +4.92% | -3.71% | -16.03% | -10.90% | 369.21 M USD | ||
| 3057 |  EBS Emergent BioSolutions Inc. Common Stock | 7.18 USD | +4.06% | +6.69% | +3.91% | -33.02% | 368.14 M USD | ||
| 3065 |  EMBC Embecta Corp. - Common Stock | 6.45 USD | +4.37% | +12.37% | +24.52% | -52.54% | 365.45 M USD | ||
| 3071 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.53 USD | -2.16% | -12.04% | -13.05% | +41.12% | 363.33 M USD | ||
| 3072 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.35 USD | +3.71% | -2.91% | -3.63% | +21.19% | 362.95 M USD | ||
| 3108 |  TTRX Turn Therapeutics Inc. - Common Stock | 11.59 USD | +4.32% | +2.20% | -15.09% | +113.84% | 345.24 M USD | ||
| 3109 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.74 USD | +1.77% | +0.17% | -4.97% | +59.44% | 345.00 M USD | ||
| 3115 |  CCCC C4 Therapeutics, Inc. - Common Stock | 2.78 USD | +6.51% | -7.33% | -20.80% | +13.93% | 342.01 M USD | ||
| 3116 |  PRE Prenetics Global Limited - Class A Ordinary Share | 20.26 USD | -1.65% | -7.95% | -6.42% | +29.87% | 341.87 M USD | ||
| 3118 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 3.20 USD | -1.23% | -0.93% | -25.58% | +61.62% | 341.34 M USD | ||
| 3130 |  IRD Opus Genetics, Inc. - Common Stock | 4.05 USD | -1.22% | -9.19% | -25.82% | +8.87% | 336.94 M USD | ||
| 3142 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 11.47 USD | +2.59% | -4.97% | -10.39% | +1.96% | 334.07 M USD | ||
| 3169 |  CV CapsoVision, Inc. - Common Stock | 6.45 USD | -2.86% | -2.57% | +6.79% | +39.61% | 322.80 M USD | ||
| 3172 |  SMTI Sanara MedTech Inc. - Common Stock | 35.09 USD | -0.09% | +0.11% | -0.40% | +21.00% | 322.41 M USD | ||
| 3176 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 11.27 USD | +1.35% | -14.49% | -30.39% | -47.11% | 320.33 M USD | ||
| 3205 |  CGC Canopy Growth Corporation - Common Shares | 0.74 USD | +4.23% | -13.95% | -20.43% | -44.78% | 313.05 M USD | ||
| 3237 |  AGEN Agenus Inc. - Common Stock | 6.68 USD | +2.77% | -11.17% | -8.62% | +67.00% | 300.74 M USD | ||
| 3247 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 6.06 USD | +2.54% | -11.40% | -30.02% | +45.67% | 296.27 M USD | ||
| 3254 |  BNTC Benitec Biopharma Inc. - Common Stock | 8.46 USD | +2.05% | -2.98% | -24.93% | -49.07% | 295.11 M USD | ||
| 3256 |  SRZN Surrozen, Inc. - Common Stock | 25.07 USD | +5.56% | -10.01% | +45.17% | +85.70% | 294.66 M USD |
ニュース ヘルスケア株
UBS、Solid Biosciencesのカバレッジを開始、投資判断は「買い」、目標株価20ドルを発表
MacroGenics、進行固形腫瘍患者を対象とした、非開示標的に向けた抗体薬物複合体MGC030の第1相試験で最初の患者への投与を開始
木曜日の取引中に動いたヘルスケア株12銘柄
Dyadic Internationalの13G提出書類は、Empery Asset Managementが9月30日時点で同社株式8.35%を保有していると報告していることを示す
NeurAxis、医療ポリシーの適用対象が2,600万人超の医療保険加入者に拡大したと発表
Edesa Biotech、尋常性白斑におけるEB06の第2相臨床試験に関する治験薬（IND）申請についてFDAの承認を取得
Wedbush、Sutro Biopharmaの「アウトパフォーム」を再確認、目標株価60ドルを維持
上昇銘柄ヘルスケア株
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
下落銘柄ヘルスケア株
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |